• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 99 of 100
CVS Caremark Reports Quarterly Profit Increase Of 25 Percent
RetailCVS Health’s tobacco ban hits retail sales after one month
By Laura LorenzettiNovember 4, 2014
Chris Viehbacher, Chief Executive Officer Of Sanofi Interview
LeadershipSanofi’s CEO ouster: A snowball of bad judgment calls
By Eleanor BloxhamOctober 30, 2014
Chris Viehbacher, Chief Executive Officer Of Sanofi Interview
LeadershipSanofi fires CEO after profit warning on key drug
By Geoffrey SmithOctober 29, 2014
FeaturesGoogle X goes teeny-tiny to diagnose disease at its earliest stages
By Laura LorenzettiOctober 28, 2014
FinancePfizer’s sales beats expectations even as top drugs lose patent protections
By Laura LorenzettiOctober 28, 2014
NIGERIA-HEALTH-DISEASE-EPIDEMIC-EBOLA-LIBERIA
EyebrowTechnical hurdles, not funding, could hinder race for Ebola vaccines
By ReutersOctober 27, 2014
Laid-Off Workers Get Employment Tips And Free Botox Treatments
FinanceAllergan firms up its profit as it continues to rebuff Valeant’s advances
By Laura LorenzettiOctober 27, 2014
Technology
FinanceMerck’s cost cutting pays off as results beat expectations
By Laura LorenzettiOctober 27, 2014
BRITAIN-PHARMACEUTICAL-GSK
FinanceGlaxoSmithKline moving forward with Ebola vaccine
By Laura LorenzettiOctober 22, 2014
FinanceDaniel Loeb urges Amgen to split into two companies
By ReutersOctober 21, 2014
Management
LeadershipThe top 10 best-performing CEOs
By Laura LorenzettiOctober 17, 2014
77993380
FinanceEnd of the road for inversions? Abbvie drops $55 billion Shire bid
By ReutersOctober 16, 2014
FinanceAbbvie looks like dropping Shire bid after crackdown on tax inversions
By Geoffrey SmithOctober 15, 2014
Valeant Offers to Buy Allergan With Pershing's Support
FinanceValeant seen raising offer for Allergan to clinch deal
By Geoffrey SmithOctober 8, 2014
Berlin Hospital Prepares For Possible Ebola Cases
FeaturesDallas Ebola patient gets experimental drug
By TIMEOctober 7, 2014
1...
  • 96
  • 97
  • 98
  • 99
  • 100
100
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Cybersecurity
Top AI leaders are begging people not to use Moltbook, a social media platform for AI agents: It’s a ‘disaster waiting to happen’An image of a popular article
By Eva RoytburgFebruary 2, 2026
Politics
Meet the Palm Beach billionaire who paid $2 million for a private White House visit with TrumpAn image of a popular article
By Tristan BoveFebruary 3, 2026
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.